Search results for: 'detection ad response'

A digital biomarker refers to measurable data about physiological functions or behaviors collected through digital devices and technologies, such as wearables, implants, ingestible sensors, smartphones, and mobile applications. These biomarkers provide continuous, real-time insights into an individual’s health status and are used to monitor normal ...

13 Oct 2020  |  North America  |  Market Research

Increasing Adoption of Low-cost Devices with Simple Designs in Response to COVID-19 to Disrupt the US & EU-5 Ventilator Market, 2025

Rising Preference for Home-based Care, Aided by Remote Monitoring Technologies, to Drive New Growth Opportunities

Infographics

×

Revenue for the US & EU-5 ventilators market is expected to increase by 370.7% in 2020 driven by the ongoing Coronavirus 2019 (COVID-19) situation. The home care segment is expected to see a comparatively strong growth potential post-pandemic. This study assesses the revenue growth impact on different ventilator market segments. It also analyzes fu...

The molecular diagnostics industry is undergoing consolidation, requiring capital investment and faster regulatory pathways to accelerate clinical adoption. Major diagnostics and life sciences companies are acquiring proprietary testing platforms to strengthen positions in precision oncology and blood-based diagnostics. AI-enabled genomic workflow ...

27 Jan 2021  |  North America  |  Market Research

Advanced Technologies that Enhance Integrated Workflow, Productivity, Patient Safety, and Detection Capabilities Drive the Global Digital Radiography Market

Technology Strategies Shift among Manufacturers with the Emergence of Value-based Imaging

Infographics

×

Key Issues Addressed

This study presents an analysis of the global digital radiography (DR) market. It provides an in-depth breakdown of current trends, market size, revenue forecast, market penetration, and market attractiveness in 3 segments: turnkey suites, mobile DR, and DR retrofits. Regional Coverage: North America: United States and Canada; Europe: Western Euro...

Second skin diagnostics refers to the emerging class of ultra-thin, flexible biosensors designed to adhere seamlessly to the skin and continuously monitor a range of physiological signals in real time. Made from stretchable, skin-like materials, these wearables can track vital signs and biomarkers, such as temperature, hydration, glucose, and heart...

The global clinical diagnostics market is poised for strong growth, driven by increased adoption of advanced diagnostics technologies, greater investment in laboratories, and improved access to molecular and immunodiagnostic testing facilities. In 2025, the industry continued its transformation, establishing testing systems as intelligent systems...

06 May 2016  |  Asia Pacific  |  Market Research

Global Generic Pharmaceuticals Market, Forecast to 2020

Market Participants Target High Value-added Branded Generics and Biosimilars Segments

Infographics

×

The key objectives of this research service are to gain an in-depth knowledge of the major markets and therapeutic areas and organizations presenting significant growth opportunities for generics, to understand the impact of regulation on the market, and to outline the industry consolidation trends that will continue shaping the future of generics....

10 Jul 2025  |  Global  |  Technology Research

Technologies for Preventing Hospital-Acquired Infections—Innovations and Growth Opportunities

A comprehensive look at the role of AI, automation, and digital surveillance technologies, showcasing the innovations that drives towards real-time detection and prevention strategies of hospital-acquired infections

Infographics

×

Hospital-acquired infections (HAI) occur 48 hours or more after hospital visit and were not present at the time of admission. Globally, around 136 million people are affected by HAIs every year. This increases the mortality rate and economic burden due to extended hospitalization and treatment. This report provides a comprehensive overview of vario...

23 Aug 2022  |  North America  |  Frost Radar

Frost Radar™: US Liquid Biopsy, 2022

A Benchmarking System to Spark Companies to Action - Innovation that Fuels New Deal Flow and Growth Pipelines

Infographics

×

The oncology space is maturing rapidly. With the arrival of blood-based assays for cancer screening and the emphasis on early detection, the liquid biopsy segment is seeing increased consolidation and high-impact acquisitions, such as Illumina and GRAIL, Exact Sciences and Thrive Earlier Detection, and Roche Foundation Medicine and Lexent Bio. Comp...